Cargando…
PBOX-15, a novel microtubule targeting agent, induces apoptosis, upregulates death receptors, and potentiates TRAIL-mediated apoptosis in multiple myeloma cells
BACKGROUND: In recent years, much progress has been made in the treatment of multiple myeloma. However, a major limitation of existing chemotherapeutic drugs is the eventual emergence of resistance; hence, the development of novel agents with new mechanisms of action is pertinent. Here, we describe...
Autores principales: | Maginn, E N, Browne, P V, Hayden, P, Vandenberghe, E, MacDonagh, B, Evans, P, Goodyer, M, Tewari, P, Campiani, G, Butini, S, Williams, D C, Zisterer, D M, Lawler, M P, McElligott, A M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031893/ https://www.ncbi.nlm.nih.gov/pubmed/21179037 http://dx.doi.org/10.1038/sj.bjc.6606035 |
Ejemplares similares
-
The pyrrolo-1,5-benzoxazepine, PBOX-15, enhances TRAIL-induced apoptosis by upregulation of DR5 and downregulation of core cell survival proteins in acute lymphoblastic leukaemia cells
por: NATHWANI, SEEMA-MARIA, et al.
Publicado: (2016) -
Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo
por: Bright, S A, et al.
Publicado: (2010) -
Induction of apoptosis in experimental human B cell lymphomas by conditional TRAIL-expressing T cells
por: Ucur, E, et al.
Publicado: (2003) -
α-Tocopheryl succinate and TRAIL selectively synergise in induction of apoptosis in human malignant mesothelioma cells
por: Tomasetti, M, et al.
Publicado: (2004) -
Pre-clinical evaluation of a novel class of anti-cancer agents, the Pyrrolo-1, 5-benzoxazepines
por: Greene, LM, et al.
Publicado: (2016)